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Development of a Short Version of the Cataldo Lung Cancer Stigma Scale 
Background and Significance 
The purpose of this study was to develop a psychometrically sound shortened 
version of an existing measure of lung cancer stigma for use by researchers and 
clinicians. Lung cancer stigma is an influential variable in the timing of help-seeking 
behavior in individuals with symptoms suggestive of lung cancer (Cataldo, Slaughter, 
Jahan, Pongquan, & Hwang, 2011; Else-Quest, LoConte, Schiller, & Hyde, 2009). Lung 
cancer is the deadliest cancer worldwide with an estimated 1.6 million new diagnoses 
and 1.4 million deaths annually (Bray, Ren, Masuyer, & Ferlay, 2012) and a five-year 
relative survival rate of 16% (ACS, 2013).  
Cancer-related stigma has historically evolved from a fear of suffering and death 
(Muzzin, Anderson, Figueredo, & Gudelis, 1994; Stahly, 1989). For lung cancer, the 
perception of the disease has been shaped by tobacco abuse resulting in a stigma 
surrounding the disease (Chapple, Ziebland, & McPherson, 2004). Individuals with lung 
cancer frequently experience a perceived stigma related to their diagnosis regardless of 
their smoking status (Cataldo et al., 2011). Current smokers, former smokers, and never 
smokers have reported stigmatization from healthcare providers, family members, and 
friends because lung cancer is so strongly associated with smoking (Cataldo, Jahan, & 
Pongquan, 2012). Therefore, stigma related to lung cancer is important to explore in 
clinical and research settings. Lung cancer patients are frequently diagnosed at an 
advanced stage (Ferlay et al., 2010; Jemal et al., 2011), and patient burden with survey 
completion may be higher. A short measure of lung cancer stigma is needed to reduce 
patient burden. 
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Review of Literature 
Stigma has long been associated with illnesses that were either poorly 
understood, poorly defined, lacked effective treatment, and frankly invoked fear within a 
population (Lebel & Devins, 2008; Stutterheim et al., 2011; Weiss & Ramakrishna, 
2006). The stigma associated with lung cancer is one of tobacco use blame and self-
blame of the individual’s own behavior (Bell, Salmon, Bowers, Bell, & McCullough, 
2010; Cataldo et al., 2011; Chapple et al., 2004; Else-Quest et al., 2009). Whether or 
not an individual smokes, he or she frequently perceives stigmatization from healthcare 
providers, friends, and family members because the disease is strongly associated with 
smoking (Cataldo et al., 2012). 
The Cataldo Lung Cancer Stigma Scale (CLCSS) has been used to measure 
self-perceived lung cancer stigma in outpatient lung cancer patients (Cataldo et al., 
2011), in lung cancer patients with depression (Cataldo et al., 2012), and in lung cancer 
patients exploring the relationship of lung cancer stigma to patient distress and 
individual quality of life (Lee & Kim, 2011). Although the instrument is written at the 
Flesch-Kinkaid Index fifth-grade reading level (Cataldo et al., 2011), the length of the 
instrument (31 items) may be burdensome to individuals with lung cancer. A shortened 
version of the CLCSS would be a valuable tool for use by researchers working with a 
study population of lung cancer patients as well as clinicians to assess lung cancer-
related stigma in their patients. The specific aims of this study were to: (a) investigate 
the dimensionality of the original CLCSS in a sample of lung cancer patients; (b) 
evaluate the internal consistency reliability of the original CLCSS; and (c) shorten the 
CLCSS using exploratory factor analysis and reliability indicators. 
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Methods 
Design 
 Data for this secondary analysis were collected in a cross-sectional study of 
outpatient lung cancer patients. The original study explored the influence of healthcare 
system distrust, lung cancer stigma, and smoking status on the timing of help-seeking 
behavior in individuals with symptoms suggestive of lung cancer. 
Sample and Setting 
 The sample consisted of outpatients with all four stages of lung cancer. 
Participants (N = 94) were recruited from December 2012 to February 2013 from two 
sites in Louisville, Kentucky: (a) an outpatient thoracic oncology clinic in an urban, 
academic medical center; and (b) an outpatient radiation oncology clinic in a private 
community-based hospital. Individuals were eligible for enrollment into the study if they 
were age 22 or older, able to speak and understand English, diagnosed with lung 
cancer as the primary site of cancer, and had knowledge of their lung cancer stage.  
Measure 
 Lung cancer stigma was measured using the 31-item CLCSS. Cataldo and 
colleagues (2011) developed the CLCSS to measure perceived stigma in lung cancer 
patients. The CLCSS was derived from the HIV Stigma Scale (Berger, Ferrans, & 
Lashley, 2001) because of similarities in experience of perceived self-infliction of the 
disease process (Cataldo et al., 2011). Cataldo et al. (2011) used the conceptual model 
of perceived stigma from the HIV Stigma Scale (Berger et al., 2001) to adapt a model of 
health-related stigma in patients with lung cancer for development of the CLCSS. The 
conceptual model served as a guide noting “the perceived stigma of lung cancer occurs 
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in the context of two factors: a person’s perception of societal attitudes toward both 
smoking and lung cancer and a personal knowledge of having lung cancer” (Cataldo et 
al., 2011, p. E47). The CLCSS was modified for use in a sample of lung cancer patients. 
Content validity of the original scale was ensured by the inclusion of experts on stigma 
from psychology, sociology, oncology, and nursing. If an item was rejected by more 
than one of the seven reviewers, it was discarded or rewritten resulting in a reduction of 
the original 45-item scale to 37 items. Nine additional items were developed, reviewed, 
and accepted by the content experts resulting in a 46-item scale initially. The CLCSS is 
based upon a 4-point Likert scale anchored by 1 (strongly disagree) and 4 (strongly 
agree). 
 Psychometric testing of the original scale was conducted with 186 lung cancer 
patients (Cataldo et al., 2011). Construct validity was supported and involved 
exploratory factor analysis which revealed four underlying subscales: (a) stigma and 
shame, (b) social isolation, (c) discrimination, and (d) smoking. The four-factor solution 
explained 57% of the variance. According to Stevens (2009), greater than 50% 
cumulative explained variance is considered ‘excellent’ in factor analysis. Using an 
eigenvalue greater > 1 criterion for the subscales and a loading cutoff of .35, 43 of the 
46 items were retained. Criterion-related validity was supported by examining the 
relationship of the 43-item instrument with the pre-identified related constructs (Cataldo 
et al., 2011): self-esteem (measured using the Rosenberg Self-Esteem Scale; Wiley, 
1989), depression (measured using the Center for Epidemiologic Studies-Depression 
Scale; Hoover et al., 1993), social support and social conflict (both measured using the 
Social Support indices; O’Brien, Wortman, Kessler, & Joseph, 1993), and quality of life 
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(measured using the Quality of Life Inventory; Ferrell, Wisdom, & Wenzl, 1989). Internal 
consistency reliability was assessed with Cronbach’s alpha and was noted to be .98. 
The Cronbach’s alphas for the four subscales were: .97 (stigma and shame), .98 (social 
isolation), .95 (discrimination), and .75 (smoking). 
The original CLCSS was then shortened to a 31-item lung cancer stigma scale to 
decrease patient burden after it was determined the scale could be shortened while 
maintaining an adequate internal consistency reliability (Cataldo et al., 2011). The 31-
item, 4-point Likert scale has a range from 31 (reflecting low levels of lung cancer 
stigma) to 124 (reflecting high levels of lung cancer stigma). In the factor analysis for the 
original scale by Cataldo et al. (2011), there were six scale items noted with double 
factor loadings: Some told me lung cancer is what I deserved for smoking (.49 factor 
loading on component 1, .44 factor loading on component 2); My lung cancer diagnosis 
was delayed because my healthcare provider did not take my “smoker’s cough” 
seriously (.48 factor loading on component 1, .40 factor loading on component 2); Most 
are uncomfortable around someone with lung cancer (.47 factor loading on component 
2, .50 factor loading on component 3); I worry that people may judge me when they 
learn I have lung cancer (.45 factor loading on component 1, .45 factor loading on 
component 3); People with lung cancer lose jobs when employers learn (.42 factor 
loading on component 2, .44 factor loading on component 3); and Healthcare providers 
don’t take “smoker’s cough” seriously (.33 factor loading on component 2, .35 factor 
loading on component 4). One scale item – I worry about people discriminating against 
me – had a triple factor loading of .45 on component 1, .48 on component 2, and .43 on 
component 3. In addition to double loadings, the scale item – Healthcare providers don’t 
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take “smoker’s cough” seriously – had low factor loadings of .33 on component 2 and 
.35 on component 4 using a cutoff loading of .40. Finally, component 3 – the 
discrimination subscale – only had one strong primary loading of .70 (People with lung 
cancer are treated like outcasts). The double and triple loadings, low loadings, and 
solitary loading on a single component supported the need for further psychometric 
analysis of the dimensionality of the scale and provided a rationale for considering a 
shorter version of the 31-item CLCSS. 
 The CLCSS is a relatively new instrument and, to date, has been used in two 
published studies. Cataldo, Jahan, and Pongquan (2012) used the CLCSS to examine 
lung cancer stigma in lung cancer patients with depression; Lee and Kim (2011) used 
the CLCSS to examine the relationships of lung cancer stigma, distress, and quality of 
life in lung cancer patients. Both studies supported the reliability and validity of the 
instrument. 
Procedure 
The university institutional review board and review committees at both 
recruitment sites approved the study. Data were collected in-person using a self-
administered survey in the clinic prior to an oncology visit. Data were analyzed using the 
Statistical Program for Social Sciences software version 20.0 (SPSS, 2012). 
Dimensionality of the 31 items of the CLCSS was evaluated using principal 
components analysis. To assess the suitability of the data for factor analysis, Bartlett’s 
test for sphericity and the Kaiser-Meyer-Olkin (KMO) statistic were used. Eigenvalues 
greater than 1 were examined first but those located above the elbow on the scree plot 
were used to make the final determination of the number of factors to retain for rotation. 
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Reliability statistics including Cronbach’s alpha, corrected item-total correlations, and 
alphas-if-item-deleted were used for scale and subscale refinement. Principal 
components analysis with varimax rotation was performed. 
Results 
Sample Characteristics 
 Characteristics of the sample are summarized in Table 1. The majority of 
participants were female, married, and age 60 years or older. More than three-fourths 
had advanced stage lung cancer. 
Psychometric Testing of the Original CLCSS 
Dimensionality. 
Cronbach’s alpha for the 31 items was .95, indicating excellent internal 
consistency reliability but potential item redundancy. Three principal components 
analyses were run. The significant Bartlett’s test of sphericity (p < .001) and the high 
KMO index (.87) indicated that the data were appropriate for this analysis. On the basis 
of the scree plot, one primary component emerged explaining 50% of the variance. Four 
other components had eigenvalues greater than 1. These components explained an 
additional 9%, 7%, 5%, and 4% of the variance. In examining the component matrix, 23 
items loaded strongly on the first component, three items loaded strongly on the second 
component, and one item loaded strongly on the fourth component. The third 
component did not have any strong loadings; four items double loaded. After further 
examination of the scree plot, three factors were retained for rotation. Nine items had 
double loadings and one item had low loadings on all three components (See Table 2). 
Items were eliminated if they had double loadings (defined as a minimum of .32; 
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Tabachnick & Fidell, 2001). These 10 items were excluded and a final principal 
components analysis with varimax rotation of three factors was run with the remaining 
21 items (see Table 3). All items loaded strongly on either the first, second or third 
component. No double loadings were noted. Items loading on each factor were 
examined and the three factors were named. Factor 1 – shame and blame– had eight 
loadings that ranged from .60 to .83. Factor 2 – social isolation– had nine loadings that 
ranged from .47 to .88. Factor 3 – discrimination – had four primary loadings that 
ranged from .74 to .94. The three factors explained 68% of the item variance. 
Internal consistency reliability. 
 Table 4 provides a summary of the reliability coefficients of the original CLCSS 
and subscales and the shortened version of the CLCSS and subscales. All three 
subscales of the shortened version had strong internal consistency reliability. The item 
with the lowest corrected item-total correlation (.37) was My lung cancer diagnosis was 
delayed because my healthcare provider did not take my “smoker’s cough” seriously. 
For the revised CLCSS, the corrected item-total correlations for Factor 1 (shame and 
blame subscale) ranged from .58 to .86, Factor 2 (social isolation subscale) ranged from 
.37 to .85, and Factor 3 (discrimination subscale) ranged from .70 to .89. There were 
moderate intercorrelations among the subscales: .69 between shame and blame and 
social isolation; .47 between shame and blame and discrimination; and .44 between 
social isolation and discrimination.  All intercorrelations were statistically significant (p < 
.001). 
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Discussion 
 In this study, we examined the psychometric properties of the original CLCSS 
(Cataldo et al., 2011) and developed a short version for use by researchers and 
clinicians working with lung cancer patients. In a sample of lung cancer patients, the 
original CLCSS had excellent internal consistency reliability but potential item 
redundancy. The original scale contains 31 items and evidence to support reliability and 
validity (Cataldo et al., 2011; Cataldo et al., 2012; Lee & Kim, 2011). By examining the 
dimensionality of the original CLCSS, we were able to shorten the scale to 21 items and 
improve the practicality of the instrument’s use in research and clinical practice. The 
shorter version will also reduce lung cancer patient burden with questionnaire 
completion. 
In our sample, internal consistency reliability of the three subscales of the short 
version were strong and ranged from .89 to .92; all scale items strongly loaded onto 
only one factor. Cronbach’s alpha for the total 21-item scale (.93) demonstrated strong 
evidence of internal consistency reliability of the short measure in this sample of lung 
cancer patients. 
From a clinical standpoint, the subscales of the short version of the CLCSS offer 
an opportunity to tailor lung cancer stigma assessment and interventions. For example, 
if an individual lung cancer patient is a never smoker and scores high on the social 
isolation subscale but low on the smoking and shame and blame subscales, 
interventions can be tailored to focus on the social isolation aspect of a lung cancer 
diagnosis. Future research should be focused on validation of the short version of the 
CLCSS and its subscales. 
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Limitations 
 The average age of a lung cancer patient is 71 years (ACS, 2013). The average 
age of the participants in this study was 62 years. Younger individuals may perceive 
stigma differently than their older counterpart. In addition, sample size may be a 
weakness. Although the sample size was sufficient for factor analysis, future studies 
testing the psychometric properties of the shortened version of the CLCSS should use 
larger samples. 
Conclusion 
 Lung cancer stigma is an important phenomenon experienced by many lung 
cancer patients. Perceived stigma in individuals with lung cancer can serve as a barrier 
to healthcare help-seeking behavior, treatment adherence, and social support. The 21-
item version of the CLCSS had strong evidence of reliability. In comparison to the 
original CLCSS, this short version may decrease patient burden and be more applicable 
to clinicians; however, future research is needed to further examine its psychometric 
properties. 
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Table 1 
Characteristics of the Persons with Lung Cancer (N = 94) 
Variable n % 
Age (years) 
   44 – 49 
   50 – 59 
   60 – 69 
   70 – 79 
   80 or older 
Education 
   Less than high school 
   High school graduate 
   Some college 
   College graduate or higher 
Gender 
   Male 
   Female 
Ethnicity 
   Caucasian 
   African-American 
Work Status 
   Employed Full-Time 
   Employed Part-Time 
   Self-Employed 
   Unemployed 
 
  7 
32 
35 
17 
  3 
 
  3 
38 
20 
33 
 
36 
58 
 
78 
16 
 
23 
  7 
  3 
12 
 
  7 
34 
37 
18 
.03 
 
  3 
40 
21 
35 
 
38 
62 
 
83 
17 
   
25 
  7 
  3 
13 
Variable n % 
   Retired 
Income 
   Less than $25,000 
   $25,000 - $50,000 
   Greater than $50,000 
Smoked 100 Cigarettes in Lifetime 
   Yes 
   No 
Smoker at Diagnosis 
   Yes 
   No 
Lung Cancer Stage at Diagnosis 
   Stage 1 
   Stage 2 
   Stage 3 
   Stage 4 
49 
 
17 
31 
46 
 
64 
30 
 
31 
33 
 
  7 
14 
29 
44 
52 
 
18 
33 
49 
 
68 
32 
 
33 
35 
 
  7 
15 
31 
47 
  Note. Because of rounding, not all percentages add up to 100. 
 
Table 2 
Factor Loadings of the Original CLCSS Items with Principal Components Analysis with  
Varimax Rotation (N = 94) 
 Factor a 
Item I II III 
1. Having lung cancer makes me feel like I’m a bad person.* 
2. I’m very careful whom I tell I have lung cancer.* 
3. Having lung cancer makes me feel like I’m a bad person.* 
4. I work hard to keep my lung cancer a secret.* 
5. I feel I’m not as good as others because I have lung cancer.* 
6. I feel set apart, isolated from the rest of the world.* 
7. Smokers could be refused treatment for lung cancer.* 
8. People with lung cancer lose jobs when employers learn.* 
9. Some people who know have grown more distant.* 
10. I was hurt how people reacted to learning I have lung cancer.* 
11. I stopped socializing with some because of their reactions.* 
12. People avoid you because lung cancer is associated with 
death.* 
13. People I care about stopped calling after learning that I have 
lung cancer.* 
14. People have physically backed away from me.* 
15. Most people are uncomfortable around someone with lung 
cancer.* 
16. Some told me lung cancer is what I deserved for smoking.* 
17. My lung cancer diagnosis was delayed because my 
.81 
.80 
.80 
.79 
.77 
.76 
.64 
.55 
.24 
.33 
.29 
.39 
 
.38 
 
.18 
.24 
 
.22 
-.26 
.19 
.37 
.33 
.33 
.02 
.18 
.11 
.15 
.87 
.83 
.78 
.75 
 
.74 
 
.68 
.57 
 
.48 
.42 
.27 
.19 
.13 
.10 
.14 
.22 
.18 
.19 
.13 
.04 
.06 
.18 
 
.21 
 
.39 
.36 
 
.39 
.32 
 Factor a 
Item I II III 
healthcare provider did not take my “smoker’s cough” 
seriously.* 
18. Others assume that a patient’s lung cancer was caused by 
smoking, even if he or she never smoked.* 
19. Others assume that a patient’s lung cancer was caused by 
smoking, even if he or she had stopped smoking years ago.* 
20. Lung cancer is viewed as a self-inflicted disease.* 
21. Some people act as though it is my fault that I have lung 
cancer.* 
22. People seem afraid of me because I have lung cancer. 
23. I worry about people discriminating against me. 
24. Most people believe a person with lung cancer is dirty. 
25. People avoid touching me if they know I have lung cancer. 
26. I worry that people may judge me when they learn I have lung 
cancer. 
27. People with lung cancer are treated like outcasts. 
28. I have lost friends by telling them I have lung cancer. 
29. I feel guilty because I have lung cancer. 
30. Healthcare providers don’t take “smoker’s cough” seriously. 
31. My lung cancer diagnosis was delayed because I put off going 
to the doctor. 
 
 
.20 
 
.20 
 
.15 
.29 
 
.66 
.66 
.63 
.62 
.61 
 
.60 
.58 
.55 
.13 
.34 
 
 
 
-.02 
 
.03 
 
.28 
.23 
 
.60 
.59 
.61 
.61 
.55 
 
.57 
.60 
.42 
.51 
.17 
 
 
.90 
 
.89 
 
.77 
.75 
 
.15 
.00 
.15 
.26 
-.04 
 
.31 
.10 
.06 
.55 
.25 
 
a Factor I   = Shame and Blame 
  Factor II  = Social Isolation 
  Factor III = Discrimination 
* Items retained for the shortened CLCSS !
Table 3 
Factor Loadings for the Shortened Version – Cataldo Lung Cancer Stigma Scale (N = 94) 
  Factor a  
Item I II III 
1. Having lung cancer makes me feel unclean. 
2. I’m very careful whom I tell I have lung cancer. 
3. I feel I’m not as good as others because I have lung 
cancer. 
4. I feel set apart, isolated from the rest of the world. 
5. Having lung cancer makes me feel like I’m a bad person. 
6. I work hard to keep my lung cancer a secret. 
7. Smokers could be refused treatment for lung cancer. 
8. People with lung cancer lost jobs when employers learn. 
9. Some people who know have grown more distant. 
10. I was hurt how people reacted to learning I have lung 
cancer. 
11. I stopped socializing with some because of their reaction. 
12. People avoid you because lung cancer is associated with 
death. 
13. People I care about stopped calling after learning that I 
have lung cancer. 
14. People have physically backed away from me. 
15. Most people are uncomfortable around someone with lung 
cancer. 
16. Some told me lung cancer is what I deserved for smoking. 
.83 
.82 
.80 
 
.80 
.79 
.78 
.71 
.60 
.28 
.34 
 
.27 
.42 
 
.38 
 
.21 
.24 
 
.30 
.19 
.36 
.03 
 
.20 
.32 
.30 
.21 
.17 
.88 
.82 
 
.76 
.75 
 
.75 
 
.72 
.59 
 
.54 
.23 
.15 
.13 
 
.17 
.13 
.12 
.10 
.11 
.03 
-.03 
 
.06 
.10 
 
.17 
 
.34 
.33 
 
.29 
  Factor a  
Item I II III 
17. My lung cancer diagnosis was delayed because my 
healthcare provider did not take my “smoker’s cough” 
seriously. 
18. Others assume that a patient’s lung cancer was caused by 
smoking, even if he or she never smoked. 
19. Others assume that a patient’s lung cancer was caused by 
smoking, even if he or she had stopped smoking years 
ago. 
20. Lung cancer is viewed as a self-inflicted disease. 
21. Some people act as though it is my fault that I have lung 
cancer. 
-.17 
 
 
.16 
 
.15 
 
 
.15 
.28 
.47 
 
 
.05 
 
.09 
 
 
.35 
.28 
.16 
 
 
.94 
 
.94 
 
 
.75 
.74 
a Factor I   = Shame and Blame 
  Factor II  = Social Isolation 
  Factor III = Discrimination !
Table 4 
Reliability Coefficients for the Original Cataldo Lung Cancer Stigma Scale and Subscales and 
the Shortened Version – Cataldo Lung Cancer Stigma Scale and Subscales (N = 94) 
 
 
 
Scale/Subscale 
 
 
Number of 
Items 
Range of 
Corrected 
Item-Total 
Correlations 
 
 
Coefficient 
alpha 
Total CLCSS 
Stigma and Shame 
Social Isolation 
Smoking 
Discrimination 
 
Total Short Version-CLCSS  
Shame and Blame 
Social Isolation 
Discrimination 
31 
11 
10 
 5 
 5 
 
21 
 8 
 9 
 4 
.24 - .76 
.12 - .79 
.71 - .85 
.54 - .81 
.54 - .84 
 
.24 - .76 
.58 - .86 
.37 - .85 
.70 - .89 
.95 
.85 
.96 
.89 
.85 
 
.93 
.92 
.89 
.91 
  !
